JBC Anatrace, Inc.

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M700253200 on March 28, 2007

J. Biol. Chem., Vol. 282, Issue 21, 15667-15678, May 25, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/21/15667    most recent
M700253200v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rennefahrt, U. E. E.
Right arrow Articles by Peterson, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rennefahrt, U. E. E.
Right arrow Articles by Peterson, J. R.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Specificity Profiling of Pak Kinases Allows Identification of Novel Phosphorylation Sites*Formula

Ulrike E. E. Rennefahrt{ddagger}, Sean W. Deacon{ddagger}1, Sirlester A. Parker§, Karthik Devarajan{ddagger}, Alexander Beeser{ddagger}2, Jonathan Chernoff{ddagger}, Stefan Knapp, Benjamin E. Turk§, and Jeffrey R. Peterson{ddagger}3

From the {ddagger}Division of Basic Science, Fox Chase Cancer Center, Philadelphia, Pennsylvania 19111, the §Department of Pharmacology, Yale University School of Medicine, New Haven, Connecticut 06520, and the Centre for Structural Genomics, Botnar Research Centre, Oxford University, Oxford OX3 7LD, United Kingdom

The p21-activated kinases (Paks) serve as effectors of the Rho family GTPases Rac and Cdc42. The six human Paks are divided into two groups based on sequence similarity. Group I Paks (Pak1 to -3) phosphorylate a number of substrates linking this group to regulation of the cytoskeleton and both proliferative and anti-apoptotic signaling. Group II Paks (Pak4 to -6) are thought to play distinct functional roles, yet their few known substrates are also targeted by Group I Paks. To determine if the two groups recognize distinct target sequences, we used a degenerate peptide library method to comprehensively characterize the consensus phosphorylation motifs of Group I and II Paks. We find that Pak1 and Pak2 exhibit virtually identical substrate specificity that is distinct from that of Pak4. Based on structural comparisons and mutagenesis, we identified two key amino acid residues that mediate the distinct specificities of Group I and II Paks and suggest a structural basis for these differences. These results implicate, for the first time, residues from the small lobe of a kinase in substrate selectivity. Finally, we utilized the Pak1 consensus motif to predict a novel Pak1 phosphorylation site in Pix (Pak-interactive exchange factor) and demonstrate that Pak1 phosphorylates this site both in vitro and in cultured cells. Collectively, these results elucidate the specificity of Pak kinases and illustrate a general method for the identification of novel sites phosphorylated by Paks.


Received for publication, January 9, 2007 , and in revised form, March 27, 2007.

* This research was supported in part by an American Association for Cancer Research-Fox Chase Cancer Center Career Development Award in Translational Cancer Research, by Department of Defense Neurofibromatosis Research Program Grant W81XWH-05-1-0200, and by a grant from the Pennsylvania Department of Health (all to J. R. P.). Additional support was provided by the National Institutes of Health Grant CA006927 and by an appropriation from the Commonwealth of Pennsylvania to Fox Chase Cancer Center. The Structural Genomics Consortium is a registered charity (number 1097737) funded by the Wellcome Trust, GlaxoSmithKline, Genome Canada, the Canadian Institutes of Health Research, the Ontario Innovation Trust, the Ontario Research and Development Challenge Fund, the Canadian Foundation for Innovation, VINNOVA, the Knut and Alice Wallenberg Foundation, the Swedish Foundation for Strategic Research, and Karolinska Institutet. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Tables 1 and 2 and Fig. 1.

1 Supported by funding from NCI, National Institutes of Health (NIH), Grant T32 CA009035.

2 Present address: Division of Biology, Kansas State University, Manhattan, KS 66502.

3 To whom correspondence should be addressed: Division of Basic Science, Fox Chase Cancer Center, 333 Cottman Ave., Philadelphia, PA 19111. Tel.: 215-728-3568; Fax: 215-728-3574; E-mail: jeffrey.Peterson{at}fccc.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
S. J. Coniglio, S. Zavarella, and M. H. Symons
Pak1 and Pak2 Mediate Tumor Cell Invasion through Distinct Signaling Mechanisms
Mol. Cell. Biol., June 15, 2008; 28(12): 4162 - 4172.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.